Join
Live feed
·
INSIDERFilingvia Quantisnow
Atrium Therapeutics Inc. logo

Chief Strategy Officer Hoyos Rocio Martin covered exercise/tax liability with 8,320 shares, decreasing direct ownership by 18% to 38,340 units (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNA (Atrium Therapeutics Inc.) and more on Quantisnow.